SCHOTT Pharma AG & Co. KGaA (1SXP) — Cash Flow-to-Debt Ratio
SCHOTT Pharma AG & Co. KGaA (1SXP) has a Cash Flow-to-Debt Ratio of 0.12x as of September 2024, meaning its operating cash flow of €75.97 Million could theoretically repay 0% of its total liabilities (€650.00 Million) in one year. See 1SXP FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
SCHOTT Pharma AG & Co. KGaA Cash Flow-to-Debt Ratio (2020–2024)
Historical debt coverage capacity for SCHOTT Pharma AG & Co. KGaA across 5 annual periods. Also explore SCHOTT Pharma AG & Co. KGaA (1SXP) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for SCHOTT Pharma AG & Co. KGaA (2020–2024)
Year-by-year debt coverage analysis for SCHOTT Pharma AG & Co. KGaA. For market capitalisation and broader financial context, see 1SXP company net worth.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.35x | €225.33 Million | €650.00 Million | ▲ +3.0% |
| 2023 | 0.34x | €181.65 Million | €539.65 Million | ▼ -9.9% |
| 2022 | 0.37x | €182.12 Million | €487.46 Million | ▼ -9.4% |
| 2021 | 0.41x | €132.21 Million | €320.48 Million | ▲ +10.8% |
| 2020 | 0.37x | €104.40 Million | €280.36 Million | — |